Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rolke

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pneumologie (Stuttgart, Germany)|December 9, 2016
B Schmidt, H Rolke, C Oerding, et al.
Pneumologie (Stuttgart, Germany)|December 9, 2016
I Reindl, N Lambrecht, I Bork, et al.
British Journal of Cancer|July 5, 2012
Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study GroupØ Fløtten, B H Grønberg, R Bremnes, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pneumologie (Stuttgart, Germany)|December 9, 2016
B Schmidt, H Rolke, C Oerding, et al.
Pneumologie (Stuttgart, Germany)|December 9, 2016
I Reindl, N Lambrecht, I Bork, et al.
British Journal of Cancer|July 5, 2012
Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study GroupØ Fløtten, B H Grønberg, R Bremnes, et al.
Pageof 1